ERBB2 and pneumonitis: Fourteen of 84 patients (16.7%) were diagnosed with any grade interstitial lung disease (ILD)/pneumonitis, including 9 patients with HR + /HER2-low MBC (16.1%) and 5 patients with HR-/HER2-low MBC (17.9%).